In vivo invasion of head and neck squamous cell carcinoma cells does not require macrophages

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2857-2865

  Smirnova, Tatiana ^a   Adomako, Alfred ^a   Locker, Joseph ^a   Van Rooijen, Nico ^b   Prystowsky, Michael B ^a   Segall, Jeffrey E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; ENZYME INHIBITION; HEAD AND NECK CARCINOMA; IN VIVO STUDY; MACROPHAGE; MOUSE; MOUTH; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 79959382602     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.030     Document Type: Article

References (55)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249
2. Belbin TJ, Bergman A, Brandwein-Gensler M, Chen Q, Childs G, Garg M, Haigentz M, Hogue-Angeletti R, Moadel R, Negassa A, Owen R, Prystowsky MB, Schiff B, Schlecht NF, Shifteh K, Smith RV, Zheng X: Head and neck cancer: reduce and integrate for optimal outcome. Cytogenet Genome Res 2007, 118:92-109 (Pubitemid 350125246)
3. Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY: Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005, 29:167-178 (Pubitemid 40170634)
4. Bryne M, Koppang HS, Lilleng R, Kjaerheim A: Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 1992, 166:375-381
5. Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S: Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 2004, 99:1667-1674 (Pubitemid 39237489)
6. Lu CF, Huang CS, Tjiu JW, Chiang CP: Infiltrating macrophage count: a significant predictor for the progression and prognosis of oral squamous cell carcinomas in Taiwan. Head Neck 2010, 32:18-25
7. Bei R, Budillon A, Masuelli L, Cereda V, Vitolo D, Di Gennaro E, Ripavecchia V, Palumbo C, Ionna F, Losito S, Modesti A, Kraus MH, Muraro R: Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients. J Pathol 2004, 204:317-325 (Pubitemid 39430092)
8. Grandis JR, Tweardy DJ: Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993, 53:3579-3584 (Pubitemid 23229640)
9. Lothaire P, de Azambuja E, Dequanter D, Lalami Y, Sotiriou C, Andry G, Castro G Jr., Awada A: Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 2006, 28:256-269 (Pubitemid 43269893)
10. Egloff AM, Rothstein ME, Seethala R, Siegfried JM, Grandis JR, Stabile LP: Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res 2009, 15:6529-6540
11. O-Charoenrat P, Rhys-Evans P, Eccles S: Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells. Int J Cancer 2000, 88:759-765
12. Yeudall WA, Miyazaki H, Ensley JF, Cardinali M, Gutkind JS, Patel V: Uncoupling of epidermal growth factor-dependent proliferation and invasion in a model of squamous carcinoma progression. Oral Oncol 2005, 41:698-708 (Pubitemid 40981110)
13. Bruzzese F, Di Gennaro E, Avallone A, Pepe S, Arra C, Caraglia M, Tagliaferri P, Budillon A: Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN- 2864 Smirnova et al AJP June 2011, Vol. 178, No. 6 alpha in head and neck cancer cells in vitro and in vivo. Clin Cancer Res 2006, 12:617-625 (Pubitemid 43166157)
14. Johns TG, Luwor RB, Murone C, Walker F, Weinstock J, Vitali AA, Perera RM, Jungbluth AA, Stockert E, Old LJ, Nice EC, Burgess AW, Scott AM: Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478, Proc Natl Acad Sci U S A 2003, 100:15871-15876 (Pubitemid 38021082)
15. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, Stanley ER, Segall JE, Condeelis JS: Macrophages promote the invasionof breast carcinoma cells via a col ony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005, 65:5278-5283 (Pubitemid 40827339)
16. Oka Y, Orth DN: Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J Clin Invest 1983, 72: 249-259 (Pubitemid 13025866)
17. Kurobe M, Furukawa S, Hayashi K: Synthesis and secretion of an epidermal growth factor (EGF) by human fibroblast cells in culture. Biochem Biophys Res Commun 1985, 131:1080-1085 (Pubitemid 16234295)
18. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348 (Pubitemid 40692295)
19. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002, 420: 860-867 (Pubitemid 36019639)
20. Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9:239-252
21. Lewis CE, Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006, 66:605-612 (Pubitemid 43165918)
22. Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, Islam M, Paul S, Pan Q, Hanash S, Kuick R, Merajver SD, Teknos TN: Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 2004, 101:2779-2787
23. Hernandez L, Smirnova T, Kedrin D, Wyckoff J, Zhu L, Stanley ER, Cox D, Muller WJ, Pollard JW, Van Rooijen N, Segall JE: The EGF/ CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12. Cancer Res 2009, 69:3221-3227
24. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J: A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004, 64:7022-7029 (Pubitemid 39331012)
25. Hernandez L, Smirnova T, Wyckoff J, Condeelis J, Segall JE: In vivo assay for tumor cell invasion. Methods Mol Biol 2009, 571:227-238
26. Henson B, Li F, Coatney DD, Carey TE, Mitra RS, Kirkwood KL, D'Silva NJ: An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma. J Oral Pathol Med 2007, 36:363-370 (Pubitemid 46889879)
27. Wyckoff JB, Segall JE, Condeelis JS: The collection of the motile population of cells from a living tumor. Cancer Res 2000, 60:5401-5404
28. van Rooijen N, van Kesteren-Hendrikx E: "In vivo" depletion of macrophages by liposome-mediated "suicide." Methods Enzymol 2003, 373:3-16 (Pubitemid 41103273)
29. Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981, 11:805-815 (Pubitemid 12237981)
30. Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW: Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer 2001, 93:781-785 (Pubitemid 32756746)
31. Stevenson PH, Stevenson JR: Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages. Calcif Tissue Int 1986, 38:227-233 (Pubitemid 16137016)
32. Wang DF, Lou N, Zeng CG, Zhang X, Chen FJ: Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma. Chin J Cancer 2009, 28:154-158
33. Cohen MH, Williams GA, Sridhara R, Chen G, McGuinn WD Jr., Morse D, Abraham S, Rahman A, Liang C, Lostritto R, Baird A, Pazdur R: United States Food and Drug Administration Drug Approval summary: gefitinib (ZD1839; Iressa) tablets. Clin Cancer Res 2004, 10:1212-1218 (Pubitemid 38365209)
34. Hatse S, Princen K, Bridger G, De Clercq E, Schols D: Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 2002, 527:255-262 (Pubitemid 35253875)
35. Bhola NE, Grandis JR: Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer. Front Biosci 2008, 13:1857-1865 (Pubitemid 351599738)
36. Kalyankrishna S, Grandis JR: Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 2006, 24:2666-2672 (Pubitemid 46622088)
37. Morgan S, Grandis JR: ErbB receptors in the biology and pathology of the aerodigestive tract. Exp Cell Res 2009, 315:572-582
38. Schafer B, Marg B, Gschwind A, Ullrich A: Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival. J Biol Chem 2004, 279:47929-47938 (Pubitemid 39540944)
39. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 2004, 4:540-550 (Pubitemid 38868623)
40. Condeelis J, Pollard JW: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266 (Pubitemid 43121975)
41. Lee JI, Jin BH, Kim MA, Yoon HJ, Hong SP, Hong SD: Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:678-684
42. Oliveira-Neto HH, Silva ET, Leles CR, Mendonca EF, Alencar Rde C, Silva TA, Batista AC: Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas. Tumour Biol 2008, 29:262-271
43. Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Kita Y, Tamotsu K, Hanazono K, Owaki T, Aikou T: Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Oncol Rep 2009, 21:65-71
44. Zabel BA, Wang Y, Lewen S, Berahovich RD, Penfold ME, Zhang P, Powers J, Summers BC, Miao Z, Zhao B, Jalili A, Janowska-Wieczorek A, Jaen JC, Schall TJ: Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 2009, 183:3204-3211
45. Tan CT, Chu CY, Lu YC, Chang CC, Lin BR, Wu HH, Liu HL, Cha ST, Prakash E, Ko JY, Kuo ML: CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP- 13-dependent invasion via the ERK1/2/AP-1 pathway. Carcinogenesis 2008, 29:1519-1527
46. Porcile C, Bajetto A, Barbieri F, Barbero S, Bonavia R, Biglieri M, Pirani P, Florio T, Schettini G: Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res 2005, 308:241-253
47. Zhang Q, Bhola NE, Lui VW, Siwak DR, Thomas SM, Gubish CT, Siegfried JM, Mills GB, Shin D, Grandis JR: Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer. Mol Cancer Ther 2007, 6:1414-1424 (Pubitemid 46712005)
48. Takamune Y, Ikebe T, Nagano O, Nakayama H, Ota K, Obayashi T, Saya H, Shinohara M: ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma. Virchows Arch 2007, 450:169-177 (Pubitemid 46295234)
49. Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J: TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J 2003, 22:1114-1124 (Pubitemid 36313595)
50. Kenny PA: TACE: a new target in epidermal growth factor receptor dependent tumors. Differentiation 2007, 75:800-808 (Pubitemid 350086166)
51. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP: Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004, 164:769-779 (Pubitemid 38282960)
52. Gschwind A, Hart S, Fischer OM, Ullrich A: TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J 2003, 22:2411-2421 (Pubitemid 36604980)
53. Thomas SM, Bhola NE, Zhang Q, Contrucci SC, Wentzel AL, Freilino ML, Gooding WE, Siegfried JM, Chan DC, Grandis JR: Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Res 2006, 66: 11831-11839 (Pubitemid 46094195)
54. Kasina S, Scherle PA, Hall CL, Macoska JA: ADAM-mediated amphiregulin shedding and EGFR transactivation. Cell Prolif 2009, 42:799-812
55. Ho-Tin-Noe B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD: Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 2008, 68:6851-6858